New antibody AK1967 tested in healthy men for first time
NCT ID NCT06331884
First seen Feb 28, 2026 · Last updated May 07, 2026 · Updated 7 times
Summary
This early-phase study tested a new antibody called AK1967 (Procizumab) in 24 healthy men to see if it is safe and how the body processes it. The antibody targets a protein that may worsen heart shock. This is a first step before testing it in patients with heart problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radboud University Medical Center
Nijmegen, Gelderland, 6525, Netherlands
Conditions
Explore the condition pages connected to this study.